Crossmark

Blood flow velocity measured using the Retinal Function Imager predicts successful ranibizumab treatment in neovascular age-related macular degeneration: early prospective cohort study

Crossref DOI link: https://doi.org/10.1038/eye.2015.10

Published Online: 2015-02-27

Published Print: 2015-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Böhni, S C

Howell, J P

Bittner, M

Faes, L

Bachmann, L M

Thiel, M A

Schmid, M K
License Information

Text and Data Mining valid from 2015-02-27
More Information

Article History

Received: 5 November 2014

Accepted: 24 December 2014

First Online: 27 February 2015

Competing interests

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below